You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
順灝股份(002565.SZ):子公司擬與雲南喜科等共設雲南通灝生物科技股份有限公司
格隆匯 09-14 20:29

格隆匯 9 月 14日丨順灝股份(002565.SZ)公佈,2020年9月14日,公司控股子公司雲南綠新生物藥業有限公司(“雲南綠新”或“乙方”)、參股公司雲南喜科科技有限公司(“雲南喜科”或“丙方”)、上海綠馨電子科技有限公司(“上海綠馨”或“丁方”)、與雲南通盈藥業有限公司(“雲南通盈”或“甲方”)簽訂了《合作協議書》,擬出資共同合作設立雲南通灝生物科技股份有限公司。上述交易完成後,公司將間接持有合資公司45%股權。

此次合作共同設立合資公司是公司基於現有業務發展戰略佈局所做的規劃,合作各方可以充分發揮各自的資源及管理優勢,共同探索包括工業大麻成型霧化製品的研發、生產及工業大麻花葉及萃取後渣葉再造香料薄片在電子生物健康產品的市場機會,與公司現有研發成果和業務實現有效協同,優化公司在新型煙草製品、草本非煙產品及工業大麻產業鏈的佈局。

此次簽署的合作協議設立合資公司,出於謹慎投資原則考慮,公司將根據項目進展情況逐步進行資金投入,合資公司僅為公司參股公司,不會對公司財務狀況及生產經營造成重大不利影響,且預計合資公司短期內不會產生較大盈利。合資公司設立完成後,有助於完善公司產業鏈,提高公司競爭力為公司尋求新的利潤增長點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account